US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations

Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin AmericaMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its subsidiary HempMeds® Mexico  and its products were featured in an L.A. Weekly  article focused on the first-ever import permit granted by Mexico

Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlight Historic Year

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming YearMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE . As you can view HERE , Medical Marijuana, Inc., has long been “A Company of First”. 2016 continued to show the company’s progress

Medical Marijuana, Inc. Subsidiary HempMeds Brasil™ Begins Importation of Real Scientific Hemp Oil-X ™ Product Line Into Brazil

Consumers Looking for Zero THC Version of Real Scientific Hemp Oil (RSHO™) Products Now Have Solution From First-Ever Approved CompanyMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™)  product line is now being imported into Brazil through the company’s subsidiary, HempMeds Brasil™ . The RSHO-X™ 

Medical Marijuana Inc Announces Excitement for Recent Mexico Cannabis Regulations Vote

New Ruling Helps Move Mexico Closer to Cannabis Legalization in the CountryMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it commends the Mexican senate for voting in favor of extending regulations for certain cannabis products. With the new regulations, more people in need of cannabis and cannabidiol (CBD) for medical care will have more access to products, including our RSHO brand of products. Medical Marijuana Inc.  subsidiary

MEDICAL MARIJUANA, INC.’S INVESTMENT AXIM® BIOTECH FILES IP APPLICATION ON PROPIETARY METHOD TO EXTRACT HIGH-PURITY THC

Company’s Major Investment company Announces Filing of Protection for Proprietary Method of THC Extraction that will Achieve Highest THC Purity Level on the MarketMedical Marijuana, Inc.  (OTC: MJNA ), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC: AXIM) has filed an IP application 

U.S. PATENT ALLOWANCE GRANTED TO MEDICAL MARIJUANA, INC.’S INVESTMENT AXIM® BIOTECH FOR USE OF ALL CANNABINOIDS IN ITS CONTROLLED RELEASE CHEWING GUM

Allows Award-Winning Cannabinoid Release Chewing Gum Products to be Used as Delivery Mechanism for All Cannabinoids, Including THC, CBD, CBG, etc.Medical Marijuana, Inc.  (OTC: MJNA ) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial

MEDICAL MARIJUANA, INC.’S HEMPMEDS® MEXICO TO HOLD FIRST-EVER NATIONAL SYMPOSIUM ON MEDICAL CANNABIS FOR HEALTH PROFESSIONALS

Company Strengthens Industry Leadership Through Educating Medical Community on Therapeutic Uses of Cannabis for Treating Neurodegenerative DiseasesMedical Marijuana, Inc.  (OTC: MJNA) today announced that its subsidiary HempMeds® Mexico  will hold the first-ever symposium dedicated to providing the medical community with information about the medical value of cannabidiol (CBD) derivatives in the treatment of neurodegenerative diseases. The First National Symposium on Medical Cannabis, which will take place on Oct. 8 in Mexico City, is

There are no items matching the current filter
There are no more items matching the current filter
Back to top